Skip to main content
Cardioxyl Pharmaceuticals logo
  • Company
  • Technology
  • Product Pipeline
  • Clinical Trials
  • Investors
  • News & Events
  • Contacts

Scientific Advisory Board

Ron Borchardt, Ph.D.
Read More


John Fukuto, Ph.D.
Read More


David Kass, M.D.
Read More


Nazareno Paolocci, MD, PhD.
Read More


Hani Sabbah, Ph.D., FACC, FCCP, FAHA
Read More


Ralph Snyderman, M.D.
Read More


John Toscano, Ph.D.
Read More


Nitroxyl Technology

Cardioxyl has developed proprietary expertise in the biology, physiology and chemistry of nitroxyl donors

View More

Our Mission

Cardioxyl's mission is to realize the potential of nitroxyl technology through the development of novel therapies that improve the health and quality of life of patients with serious cardiovascular disease.

  • History of Cardioxyl
  • Management Team
  • Board of Directors
  • Clinical Advisory Board
  • Scientific Advisory Board
    • David Kass, M.D.
    • Hani Sabbah, Ph.D., FACC, FCCP, FAHA
    • John Fukuto, Ph.D.
    • John Toscano, Ph.D.
    • Nazareno Paolocci, MD, PhD.
    • Ralph Snyderman, M.D.
    • Ron Borchardt, Ph.D.
  • Scientific Founders

Privacy Policy Terms of Use Contacts


Exchange East, Suite 212
1450 Raleigh Road,
Chapel Hill, NC 27517
Main: (919) 869-8585

©2012 Cardioxyl Pharmaceuticals, Inc. All rights reserved.